Wird geladen...
Limitations in the Design of Chimeric Antigen Receptors for Cancer Therapy
Cancer therapy has entered a new era, transitioning from unspecific chemotherapeutic agents to increasingly specific immune-based therapeutic strategies. Among these, chimeric antigen receptor (CAR) T cells have shown unparalleled therapeutic potential in treating refractory hematological malignanci...
Gespeichert in:
| Veröffentlicht in: | Cells |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
MDPI
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6562702/ https://ncbi.nlm.nih.gov/pubmed/31108883 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells8050472 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|